μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief

Abstract

Rationale: The perception that smoking relieves negative affect contributes to smoking persistence. Endogenous opioid neurotransmission, and the μ-opioid receptor (MOR) in particular, plays a role in affective regulation and is modulated by nicotine.

Objectives: We examined the relationship of MOR binding availability in the amygdala to the motivation to smoke for negative affect relief and to the acute effects of smoking on affective responses.

Methods: Twenty-two smokers were scanned on two separate occasions after overnight abstinence using [¹¹C]carfentanil positron emission tomography imaging: after smoking a nicotine-containing cigarette and after smoking a denicotinized cigarette. Self-reports of smoking motives were collected at baseline, and measures of positive and negative affect were collected pre- and post- cigarette smoking.

Results: Higher MOR availability in the amygdala was associated with motivation to smoke to relieve negative affect. However, MOR availability was unrelated to changes in affect after smoking either cigarette.

Conclusions: Increased MOR availability in amygdala may underlie the motivation to smoke for negative affective relief. These results are consistent with previous data highlighting the role of MOR neurotransmission in smoking behavior.

Fig. 1. MOR BP_ND masks for each ROI

MOR BP_ND was extracted from the amygdala and the five exploratory ROIs for offline analysis.

Fig. 2. Association of NAR score with MOR BP_ND in the amygdala

Binding potentials for amygdala (adjusted for session, OPRM1 genotype, sex, FTND, and hemisphere) are plotted for each participant for both sessions. In the multiple regression models, NAR scores were significantly associated with MOR BP_ND in the amygdala (β = 0.06, p = 0.007). MOR BP_ND = µ-opioid receptor binding potential; NAR = Negative Affect Reduction score